The treatment response to new immunotherapy in advanced melanoma patients remains varied between individuals. Immune related cutaneous side effects may have prognostic value.
Continue Reading→Previous studies have found familial aggregation of melanoma and keratinocyte cancers (KCs).
Continue Reading→Anecdotal experience and data from multiple retrospective studies have suggested that a significant percentage of nonmelanoma skin cancers (NMSCs) display an aggressive histologic subtype that is not diagnosed on initial biopsy.
Continue Reading→